ESR1 and breast cancer: BC is known to be a hormone-dependent disease characterized by molecular mechanisms involving activation of human epidermal growth factor receptor 2 (HER2, encoded by ERBB2), hormone receptors (estrogen receptor and progesterone receptor) and/or BRCA mutations [2].